CSF3 and hemochromatosis type 1: Treatment strategies in lower risk patients include regular transfusions, iron chelation to prevent secondary hemochromatosis, antibiotic and antifungal therapy during potential infectious complications, and granulocyte-colony-stimulating factor (G-CSF) administration.